About Deepcell
Deepcell is a company based in Mountain View (United States) founded in 2015. Deepcell has raised $122.99 million across 5 funding rounds from investors including Leland Stanford Junior University, Koch Disruptive Technologies and Horizons Ventures. Deepcell offers products and services including REM-I Platform. Deepcell operates in a competitive market with competitors including PathAI, Viz.ai, Deciphex, Aignostics and Pictor Labs, among others.
- Headquarter Mountain View, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Deepcell, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$122.99 M (USD)
in 5 rounds
-
Latest Funding Round
$19.99 M (USD), Series C
Oct 14, 2022
-
Investors
Leland Stanford Junior University
& 10 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Deepcell
Deepcell offers a comprehensive portfolio of products and services, including REM-I Platform.
Provides AI-based imaging and sorting for single cell research applications.
People of Deepcell
Unlock access to complete
Unlock access to complete
Funding Insights of Deepcell
Deepcell has successfully raised a total of $122.99M across 5 strategic funding rounds. The most recent funding activity was a Series C round of $19.99 million completed in October 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Deepcell
Deepcell has secured backing from 11 investors, including venture fund, angel, and institutional investors. Prominent investors backing the company include Leland Stanford Junior University, Koch Disruptive Technologies and Horizons Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Multiple sectors are invested in by the venture capital firm.
|
Locked | Locked | Locked | |
|
Horizons Ventures is focused on investing in deep science and technology.
|
Locked | Locked | Locked | |
|
Investing in Life Sciences sectors like Healthcare and Biotechnology.
|
Locked | Locked | Locked |
Investor details for Deepcell
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Deepcell
Investment portfolio details for Deepcell
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Deepcell
Detailed financials for Deepcell
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Deepcell Comparisons
Peer comparison for Deepcell
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Deepcell
Deepcell operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as PathAI, Viz.ai, Deciphex, Aignostics and Pictor Labs, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of AI-based solutions for clinical diagnosis of cancer and other diseases
|
|
| Locked | Locked | Locked |
AI and cloud-powered software for stroke care coordination is developed.
|
|
| Locked | Locked | Locked |
Digital pathology software is developed for clinical and veterinary productivity.
|
|
| Locked | Locked | Locked |
AI-based pathology diagnostic software is provided for medical analysis.
|
|
| Locked | Locked | Locked |
AI-based tools for pathological image analysis are provided to labs.
|
Detailed competitors of Deepcell
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Deepcell
Complete news archive for Deepcell
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Deepcell
Deepcell was founded in 2015 and raised its 1st funding round 2 years after it was founded.
Deepcell is headquartered in Mountain View, United States. It is registered at Mountain View, California, United States.
Deepcell is a funded company, having raised a total of $122.99M across 5 funding rounds to date.
Deepcell was founded in 2015 in Mountain View, United States, within the biotechnology sector. Proprietary methods for single cell analysis are developed by integrating microfluidics, optics, and artificial intelligence. Classification and isolation technologies are applied to clinical research, enabling examination of cell phenotypes and functions to support biological inquiries. Operations focus on advancing tools for research applications across various biological fields.
Deepcell's top competitors include Aignostics, Deciphex and Pictor Labs.
Deepcell offers REM-I Platform.
Deepcell has 11 investors. Key investors include Leland Stanford Junior University, Koch Disruptive Technologies, Horizons Ventures, Casdin Capital, and Andreessen Horowitz.